CyberKnife: A Breakthrough in Non-Invasive Cancer Treatment

By Ankit SinghReviewed by Susha Cheriyedath, M.Sc.Nov 5 2024

Cancer treatment has come a long way, yet many traditional methods still require invasive procedures that can lead to discomfort and long recovery times. The CyberKnife system offers a fresh approach.

Image Credit: Mark_Kostich/Shutterstock.com

This non-invasive radiosurgery technology uses precise robotics to deliver targeted radiation, focusing only on the tumor and sparing surrounding healthy tissue. With CyberKnife, patients have access to a less intrusive treatment that is designed to be more comfortable and requires less downtime, making it a promising option, especially for treating difficult-to-reach tumors that are not ideal for traditional surgery.

The Science Behind CyberKnife

CyberKnife operates on principles of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), where high doses of radiation are delivered to a specific target with extreme accuracy. This principle is known as hypofractionation, wherein fewer high-dose sessions are administered rather than multiple low-dose sessions. Using advanced imaging and robotic guidance, CyberKnife directs radiation to within millimeters of a tumor’s edges, enhancing treatment effectiveness while reducing exposure to surrounding healthy tissue.¹

The system’s precision is achieved through fractionation, where each high dose of radiation is divided into smaller, controlled portions. This technique enables CyberKnife to effectively target cancerous cells while keeping adjacent healthy tissue as safe as possible.¹

Robotics in Healthcare: An Introduction

The Key Components Driving CyberKnife Precision

CyberKnife is a highly sophisticated radiosurgery system that consists of several integral components that enable precise targeting and radiation delivery.

• Robotic Arm: CyberKnife’s robotic arm offers a flexible range of motion, enabling it to approach tumors from various angles. This precision is especially valuable for accessing hard-to-reach areas, such as tumors in the spine and brain.¹
• Linear Accelerator (LINAC): The system’s LINAC produces high-energy X-rays, essential for delivering targeted radiation. Unlike traditional systems, CyberKnife’s LINAC is mounted on the robotic arm, allowing it to deliver radiation from multiple positions, enhancing flexibility and accuracy.¹
• Image-Guidance System: CyberKnife’s advanced imaging system is equipped with two orthogonal X-ray cameras that continuously capture real-time images. These images are then used to guide the robotic arm, ensuring accurate delivery of radiation to the targeted tumor site.¹
• Respiratory Tracking System: For tumors in the chest or abdomen, CyberKnife’s synchrony respiratory tracking system (SRTS) monitors the patient’s breathing patterns, enabling the system to adjust the radiation beam as needed. This real-time tracking maintains precision, even as the tumor moves with each breath.¹
• Treatment Planning Software: CyberKnife’s planning software allows oncologists to precisely map the tumor’s position, shape, and size and to calculate the optimal radiation dose. It also determines the best paths for radiation beams, minimizing exposure to healthy tissues and improving safety for the patient.¹

How CyberKnife Delivers Targeted Treatment

CyberKnife’s approach to delivering precise, high-dose radiation involves a carefully structured, multi-step process that maximizes accuracy and minimizes impact on surrounding tissues.

Treatment begins with patient preparation and imaging, where detailed CT or MRI scans capture the tumor’s exact size, shape, and location. This data is essential for the CyberKnife treatment planning system, which uses the information to create a personalized treatment plan. During the planning phase, oncologists determine the exact radiation dose and the most effective beam paths to target the tumor.

Once treatment begins, CyberKnife’s advanced image-guidance system continuously tracks the tumor’s position in real-time. The system’s respiratory tracking function adjusts to any movements in the patient, such as breathing, keeping the radiation focused precisely on the tumor.

During radiation delivery, CyberKnife’s robotic arm, guided by live imaging, moves around the patient to direct radiation from multiple angles, ensuring the dose is concentrated on the tumor and minimizing exposure to surrounding healthy tissue. This integrated process enables CyberKnife to deliver a highly effective, non-invasive treatment for cancer patients, combining advanced technology with meticulous planning to enhance both precision and patient comfort.¹

CyberKnife Applications Across Cancer Types

CyberKnife has been used to treat various types of cancers that benefit from high-precision radiation. It is particularly effective for treating hard-to-reach tumors, including those in the brain, spine, and lungs.

• Brain Tumors: CyberKnife is particularly effective for treating brain tumors, including primary brain tumors and metastatic tumors. The precision of CyberKnife minimizes the risk of damaging healthy brain tissue.²
• Spinal Tumors: The mobility and flexibility of the robotic arm make CyberKnife an effective option for treating spinal tumors, which are often located in areas challenging for traditional surgical approaches.²
• Lung Cancer: The SRTS enables CyberKnife to treat lung tumors with high accuracy, even while accounting for the movement caused by breathing.²
• Prostate Cancer: Prostate tumors can be difficult to treat due to their proximity to sensitive structures. CyberKnife’s precision allows for effective treatment while preserving surrounding tissues and reducing the risk of side effects.²
• Liver and Pancreatic Tumors: Tumors in the liver and pancreas are challenging to treat due to organ movement. CyberKnife’s tracking capabilities and precise radiation delivery are advantageous for these locations.²
• Head and Neck Cancers: The precision of CyberKnife allows for targeted treatment of tumors in the head and neck region, where surrounding nerves and tissues are highly sensitive.²

The Science Behind PARO: The Therapeutic Companion

The Roadblocks to CyberKnife’s Broader Reach

While CyberKnife offers many benefits, several technical and logistical challenges can limit its accessibility and overall effectiveness.

One limitation is treatment duration; although CyberKnife requires fewer sessions, each one can last up to 90 minutes, which may be difficult for patients who struggle to stay still for prolonged periods of time. Cost is another barrier, as CyberKnife treatment is expensive due to the high cost of equipment, infrastructure, and maintenance. This financial burden can make treatment inaccessible for some patients.

Accessibility is another issue, as CyberKnife systems are typically available only in specialized cancer centers, meaning that it can be challenging for patients in rural or under-resourced areas to receive this treatment. Additionally, CyberKnife’s treatment planning is highly complex, requiring input from a multidisciplinary team of radiologists, physicists, and oncologists. Coordinating these resources can be a logistical hurdle, especially in facilities with limited staffing or resources.

Finally, CyberKnife may not be ideal for all tumor types. Some tumors are less sensitive to radiation, or their positions may reduce CyberKnife’s effectiveness, making traditional surgical options more suitable in certain cases. Together, these roadblocks highlight the need for ongoing improvements to expand CyberKnife’s reach and effectiveness in cancer care.^1,3

Tech Advancements Enhancing CyberKnife Precision

With technology advancing rapidly, CyberKnife’s precision is set to improve even further, thanks to the growing role of artificial intelligence (AI) in healthcare. By incorporating AI into its planning and tracking systems, CyberKnife could predict even the smallest movements of a tumor, allowing radiation to be delivered with greater accuracy. AI could also help analyze detailed imaging data, creating treatment plans that are specifically tailored to the unique characteristics of each patient’s tumor.⁴

New developments in imaging technology also hold promise. One area being explored is real-time MRI-guided radiosurgery, which would let CyberKnife continuously “see” soft tissues during treatment. This could be especially useful for tracking tumors in organs like the liver and lungs, where natural movement occurs with each breath. These advancements have the potential to make CyberKnife even more precise and adaptable, bringing more options to patients seeking non-invasive cancer treatments.⁵

Xenex Germ-Zapping Robot: Leveraging UV Light to Revolutionize Hospital Disinfection

The Future of CyberKnife in Cancer Care

The future of CyberKnife in cancer care is filled with exciting possibilities that could make it even more effective, accessible, and widely used. Researchers are exploring how AI can be incorporated into CyberKnife’s imaging and planning software, helping it pinpoint tumors with even greater precision. With advancements in planning technology, CyberKnife could soon take on more complex cases, such as tumors near sensitive areas or those in difficult-to-reach areas.⁴

There is also promising research into combining CyberKnife with treatments like immunotherapy to enhance overall outcomes. Some clinical trials are studying how targeted radiation might boost the immune system’s response, potentially turning CyberKnife into a key part of combined cancer therapies.⁵

Efforts to make CyberKnife more accessible are also underway. Researchers are looking for ways to lower costs and even develop more portable versions of the system, which could make this technology available in more hospitals and clinics worldwide. These developments could help CyberKnife reach more patients, offering hope through cutting-edge, non-invasive cancer treatment that’s within closer reach for people everywhere.³

An Introduction to AI in Pharma

Conclusion

CyberKnife is a game-changer in cancer treatment, providing a precise, non-invasive option that stands apart from traditional surgery and radiation. With its advanced imaging, robotic precision, and adaptable design, CyberKnife has successfully treated a wide range of tumors, including those in hard-to-reach areas.

However, there are still some challenges, like high costs, limited access, and the need for complex treatment planning. Future advancements, including AI integration and real-time imaging, could make CyberKnife even more effective and available to more patients.

As technology continues to evolve, CyberKnife holds the promise of transforming cancer care, giving hope to patients who are looking for effective, less invasive treatment options.

What to Expect from the Robotics Industry by 2030

References and Further Reading

1. Kilby, W. et al. (2020). A Technical Overview of the CyberKnife System. Handbook of Robotic and Image-Guided Surgery, 15-38. DOI:10.1016/B978-0-12-814245-5.00002-5. https://www.sciencedirect.com/science/article/abs/pii/B9780128142455000025
2. Karkar, D. et al. (2023). Cyberknife treatment for different types of tumor. J of Pharmaceutical Research, 8(2), 248-252. https://www.opastpublishers.com/open-access-articles/cyberknife-treatment-for-different-types-of-tumor.pdf
3. Cheng, Y. et al. (2022). Is the CyberKnife^© radiosurgery system effective and safe for patients? An umbrella review of the evidence. Future Oncology, 18(14), 1777–1791. DOI:10.2217/fon-2021-0844. https://www.tandfonline.com/doi/abs/10.2217/fon-2021-0844
4. Iftikhar, M. et al. (2024). Artificial intelligence: revolutionizing robotic surgery: review. Annals of Medicine & Surgery. DOI:10.1097/ms9.0000000000002426. https://journals.lww.com/annals-of-medicine-and-surgery/fulltext/2024/09000/artificial_intelligence__revolutionizing_robotic.69.aspx
5. Keall, P. J. et al. (2022). Integrated MRI-guided radiotherapy — Opportunities and challenges. Nature Reviews Clinical Oncology, 19(7), 458-470. DOI:10.1038/s41571-022-00631-3. https://www.nature.com/articles/s41571-022-00631-3

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.